Skip to content

The comparison of pulmonary function and pain score in cervical epidural block

The comparison of pulmonary function in cervical interlaminar epidural steroid injection with ropivacaine : a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0004343
Enrollment
50
Registered
2019-10-17
Start date
2019-09-26
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : The patients were randomized into two groups: group 1 with 0.18% ropivacaine 4ml + dexamethasone 5mg + H-lase (Hyaluronidase), group 2 with 0.25% ropivacaine 4ml + dexamethasone 5m

Sponsors

Ewha Womans University Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who visited the Ewha Womans University Mokdong Hospital Pain Clinic, aged 19 to 70 years old, and diagnosed with cervical herniated nucleus pulposus and spinal stenosis due to questionnaire, neurological examination, and radiographic findings. The patients undergoing cervical interlaminar epidural steroid spinal injection.

Exclusion criteria

Exclusion criteria: Patients who have undergone cervical interlaminar epidural steroid spinal injection within 4 weeks prior to the procedure, taken oral steroids, anticoagulants, or drugs that affect lung function, ropivacaine or steroid hypersensitivity, cognitive dysfunction, lung function disorder, liver function disorder. If the patient or guardian disagree with the study, they are also excluded from the study.

Design outcomes

Primary

MeasureTime frame
Forced expiratory volume in one second (FEV1), Forced vital capacity (FVC), Peak expiratory flow rate (PEFR);VAS score

Secondary

MeasureTime frame
Neck Disability Index (NDI)

Countries

Korea, Republic of

Contacts

Public ContactWon-joong Kim

Ewha Womans University Medical Center

ickypoo@naver.com+82-2-2650-5230

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026